Current status of conditioning regimens in haploidentical hematopoietic cell transplantation

Current status of conditioning regimens in haploidentical hematopoietic cell transplantation

The development of effective prophylaxis strategies against graft-versus-host disease (GVHD) has contributed to the widespread use of haploidentical related hematopoietic cell transplantation (Haplo-HCT). Currently, GVHD prophylaxis containing posttransplant cyclophosphamide (PTCY) is considered the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Junichi Sugita, Masamitsu Yanada
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Hematology
Subjects:	Allogeneic hematopoietic cell transplantation conditioning haploidentical posttransplant cyclophosphamide
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2024.2332866
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Franco Aversa, et al.
Published: (2016-10-01)

Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott–Aldrich syndrome: a case report
by: Le Nguyen Ngoc Quynh, et al.
Published: (2025-02-01)

Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era
by: María Queralt Salas, et al.
Published: (2024-12-01)

Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantation
by: Sarah Kayser, et al.
Published: (2024-12-01)

Future directions in haploidentical hematopoietic stem cell transplantation
by: Pongthep Vittayawacharin, et al.
Published: (2024-12-01)

More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?
by: Moisés Manuel Gallardo-Pérez, et al.
Published: (2024-12-01)

The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors
by: Christopher Graham, et al.
Published: (2024-12-01)

COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR
by: Selim SAYIN
Published: (2024-02-01)

Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
by: Eun Seop Seo, et al.
Published: (2025-01-01)

Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
by: Eun Seop Seo, et al.
Published: (2025-02-01)

Intrathecal tocilizumab for immune-mediated central nervous system complication after haploidentical hematopoietic stem cell transplantation in children: Two case reports
by: Ruirui Gui, et al.
Published: (2024-11-01)

Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study
by: Jia Feng, et al.
Published: (2025-01-01)

The rationale behind grafting haploidentical hematopoietic stem cells
by: Richard T. Maziarz, et al.
Published: (2024-12-01)

Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children
by: Guangqiang Meng, et al.
Published: (2025-01-01)

Dual in vivo T cell depleted haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and anti-thymocyte globulin as a third salvage transplant for leukocyte adhesion deficiency with graft failure: a case report
by: Azadeh Kiumarsi, et al.
Published: (2025-01-01)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
by: Erika S Varady, et al.
Published: (2023-08-01)

Clinical Characteristics and Prognostic Factors Affecting Clinical Outcomes in Cytomegalovirus Retinitis Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Qiaozhu Zeng, et al.
Published: (2025-01-01)

Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria
by: Marek Ussowicz, et al.
Published: (2025-01-01)

Efficacy and safety of low-dose TBI combined MAC regimen for HSCT in high-risk AML patients with active disease
by: Can Chen, et al.
Published: (2025-12-01)

Comparative retrospective analysis of cord blood transplantation with ATG-containing conditioning regimens and haploidentical stem cell transplantation: similar survival outcomes with reduced incidence of GVHD
by: Yongjia Liu, et al.
Published: (2025-12-01)

Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions
by: Muhammad Azhar Ud Din, et al.
Published: (2025-01-01)

Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide in patients with inborn errors of immunity: Experience in a reference center in Colombia
by: Diego Medina, et al.
Published: (2024-12-01)

Hyperbaric oxygen therapy improves the efficacy of conventional supportive treatment for late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation
by: Yiwen Qu, et al.
Published: (2024-12-01)

Prophylactic use of liposomal amphotericin B in children and adolescents undergoing allogeneic hematopoietic cell transplantation: A 10-years single center experience
by: Laura G.Y. Rotte, et al.
Published: (2024-12-01)

Early bacteremia following allogeneic hematopoietic stem cell transplantation without antibiotic prophylaxis: epidemiology and antimicrobial resistance
by: Nour Ben Abdeljelil, et al.
Published: (2024-12-01)

A network meta-analysis of the effectiveness of different basic preconditioning regiments in allogeneic hematopoietic stem cell transplantation
by: Si-ting Wu, et al.
Published: (2024-12-01)

FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.
by: Daniele Avenoso, et al.
Published: (2023-06-01)

Post-transplant complications revealed by mycophenolate mofetil related transporters and metabolic enzymes gene polymorphisms in pediatric patients with hematological disorders
by: Qi Ji, et al.
Published: (2024-12-01)

Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature review
by: Gérôme Lombardo, et al.
Published: (2024-12-01)

VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?
by: Eva deBerranger, et al.
Published: (2024-11-01)

Case report: TP53 c.848G>A germline mutation as a possible screening target at initial diagnosis for acute lymphoblastic leukemia
by: Fang Hua, et al.
Published: (2024-12-01)

Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics
by: Haruno Oku, BS, et al.
Published: (2025-01-01)

Efficacy and safety of blinatumomab for the treatment of patients relapsing after allogeneic hematopoietic cell transplantation: a systemic review and meta-analysis
by: Huai-Peng Guo, et al.
Published: (2024-12-01)

IMPACT OF EDUCATIONAL INTERVENTIONS ON PSYCHOLOGICAL DISTRESS DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RANDOMIZED STUDY.
by: Marco Cioce, et al.
Published: (2020-08-01)

Hemangiopericytoma following allogeneic hematopoietic stem cell transplantation in a patient with primary plasma cell leukemia: the first case report and literature review
by: Yajun Shi, et al.
Published: (2024-11-01)

A novel conditioning regimen with pre-transplantation immunosuppression reduces the complication rates in hematopoietic stem cell transplantation in transfusion-dependent β-thalassemia
by: Huaqing Yang, et al.
Published: (2024-12-01)

Lesson learned in pediatric haploidentical transplantation in a low-resource environment: delivering melphalan IV and using low dose radiation reduce graft failure
by: Valentine Jiménez-Antolinez, et al.
Published: (2024-12-01)

A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL
by: Xueying Wang, et al.
Published: (2024-12-01)

Treatment of minimal residual disease in myeloid malignancies after allo-HSCT with venetoclax-based regimens in patients ineligible for or failed in the immunotherapy
by: Wen-Jing Yu, et al.
Published: (2024-12-01)